Design of new small cyclic melanocortin receptor-binding peptides using molecular modelling: Role of the His residue in the melanocortin peptide core

By Prusis P.   Muceniece R.   Mutule I.   Mutulis F.   Wikberg J.E.S.  

European Journal of Medicinal Chemistry, Vol. 36, Iss. 2, 2001-02 ,pp. : 137-146

Elsevier

Access to resources Recommend Favorite

Molecular topology as a novel approach for drug discovery

By Gálvez Jorge   Gálvez-Llompart María   García-Domenech Ramón  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 2, 2012-02 ,pp. : 133-153

Informa Healthcare

Access to resources Recommend Favorite

Design of new antineoplastic lead drugs by molecular topology

By Galvez J.   Garcia-Domenech R.   de Julian-Oritz J.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 265-268

Informa Healthcare

Access to resources Recommend Favorite

New semi-synthetic cyclic peptides as potential antifungal and antiprotozoal agents

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1293-1295

Informa Healthcare

Access to resources Recommend Favorite

Application of Molecular Topology to the Search of Novel NSAIDs: Experimental Validation of Activity

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 6, 2010-07 ,pp. : 438-445

Bentham Science Publishers

Access to resources Recommend Favorite